ATE435237T1 - Durch homogene bluttransfusion induziertes protein und für dieses kodierende dna - Google Patents

Durch homogene bluttransfusion induziertes protein und für dieses kodierende dna

Info

Publication number
ATE435237T1
ATE435237T1 AT01956777T AT01956777T ATE435237T1 AT E435237 T1 ATE435237 T1 AT E435237T1 AT 01956777 T AT01956777 T AT 01956777T AT 01956777 T AT01956777 T AT 01956777T AT E435237 T1 ATE435237 T1 AT E435237T1
Authority
AT
Austria
Prior art keywords
protein
blood transfusion
dna coding
protein induced
homogeneous blood
Prior art date
Application number
AT01956777T
Other languages
English (en)
Inventor
Hiroo Uchida
Hirokazu Tanaka
Yasuhiko Kitoh
Akio Fujimura
Eiji Kobayashi
Original Assignee
Maruho Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maruho Kk filed Critical Maruho Kk
Application granted granted Critical
Publication of ATE435237T1 publication Critical patent/ATE435237T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8114—Kunitz type inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01956777T 2000-08-09 2001-08-01 Durch homogene bluttransfusion induziertes protein und für dieses kodierende dna ATE435237T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000241169 2000-08-09
PCT/JP2001/006620 WO2002012495A1 (fr) 2000-08-09 2001-08-01 Proteine induite par transfusion sanguine homogene et adn la codant

Publications (1)

Publication Number Publication Date
ATE435237T1 true ATE435237T1 (de) 2009-07-15

Family

ID=18732399

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01956777T ATE435237T1 (de) 2000-08-09 2001-08-01 Durch homogene bluttransfusion induziertes protein und für dieses kodierende dna

Country Status (8)

Country Link
US (1) US7091316B2 (de)
EP (1) EP1312675B1 (de)
JP (1) JP4683819B2 (de)
AT (1) ATE435237T1 (de)
AU (1) AU2001278684A1 (de)
CA (1) CA2418395C (de)
DE (1) DE60139131D1 (de)
WO (1) WO2002012495A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008151426A1 (en) 2007-06-12 2008-12-18 Kinetic Spine Technologies Inc. Artificial intervertebral disc
CA2694112A1 (en) * 2007-07-20 2009-01-29 The University Of Utah Research Foundation Identification and quantification of biomarkers for evaluating the risk of preterm birth
KR20180029046A (ko) 2015-06-19 2018-03-19 세라 프로그노스틱스 인코포레이티드 조산 예측용 바이오마커 쌍
EP4530633A3 (de) 2017-08-18 2026-03-25 Sera Prognostics, Inc. Schwangerschaftstaktproteine zur vorhersage des frühstadiums und der geburtszeit

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5459063A (en) 1993-10-14 1995-10-17 The University Of Pennsylvania Plasmodium falciparum ribonucleotide reductase DNA
CA2257474A1 (en) * 1996-06-07 1997-12-11 Eli Lilly And Company Ob protein binding protein
WO1998043611A1 (en) * 1997-03-31 1998-10-08 Alza Corporation Diffusional implantable delivery system
NZ527900A (en) * 1997-12-03 2005-02-25 Genentech Inc PRO361 polypeptides and nucleic acids with homology to mucin and chitinase

Also Published As

Publication number Publication date
EP1312675A1 (de) 2003-05-21
EP1312675A4 (de) 2004-07-14
CA2418395C (en) 2010-05-04
US7091316B2 (en) 2006-08-15
AU2001278684A1 (en) 2002-02-18
DE60139131D1 (de) 2009-08-13
CA2418395A1 (en) 2002-02-14
JP4683819B2 (ja) 2011-05-18
WO2002012495A1 (fr) 2002-02-14
EP1312675B1 (de) 2009-07-01
US20050049189A1 (en) 2005-03-03

Similar Documents

Publication Publication Date Title
UA48105C2 (uk) ФРАГМЕНТ ДНК, ЯКИЙ КОДУЄ БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), РЕКОМБІНАНТНА МОЛЕКУЛА ДНК (ВАРІАНТИ), КЛІТИНА-ХАЗЯЇН (ВАРІАНТИ), СПОСІБ ОДЕРЖАННЯ БІЛКУ РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), БІЛОК РОДИНИ TGF-<font face="Symbol">b</font> (ВАРІАНТИ), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ (ВАРІАНТИ), АНТИТІЛО АБО ФРАГМЕНТ АНТИТІЛА (ВАРІАНТИ), МОЛЕКУЛА КДНК (ВАРІАНТИ)
DE60234716D1 (de) Verfahren zur Herstellung eines doppeltsträngigen Polynukleotids
PT1385950E (pt) Montagem dirigida por computador de um polinucleótido que codifica um polipéptido alvo
DE3783191D1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
DE69629181D1 (de) Wachstumsfaktor-b, spezifisch für vaskuläre endothelzellen
DE69233104D1 (de) Herstellung von Antikörpern
DK1240337T3 (da) Fremgangsmåder og præparater til forlængelse af elimeneringshalveringstider af bioaktive forbindelser
ATE410178T1 (de) Oligopeptide zur verringerung erhöhter blutharnstoffkonzentration
AU1922902A (en) Novel means for the diagnosis and therapy of CTCL
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
ATE135371T1 (de) Mit akuter pankreatitis assoziiertes protein, mittel zur diagnose von akuter pankreatitis
MXPA02008239A (es) Gen humano de la esquizofrenia.
DE60106469D1 (de) Verfahren zur Herstellung von genetisch veränderten Lymphozyten Vorläuferzellen von Wirbeltieren und deren Gebrauch zur Produktion von heterologen Bindeproteinen
EP1412388A4 (de) Von dd 3b6/22 abgeleitete humanisierte antikörper mit spezifität für das d-dimer fragment von fibrin
EP0232523A3 (en) Dna sequences which encode for proteins with the biological activity of husi-type i inhibitors, their production by gene technology and drugs containing these proteins
ATE435237T1 (de) Durch homogene bluttransfusion induziertes protein und für dieses kodierende dna
IL154298A0 (en) Papap proteins, their preparation and use
DE69321720D1 (de) Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
EP0206200A3 (en) Human cholinesterase-type proteins and their production
DE69533626D1 (de) Tioredioxine h aus zwig und hart-weizen und ähnliche proteine, diese kodierende dna-fragmente und verfahren zu ihrer herstellung
DE50010015D1 (de) Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung
DE602006015444D1 (de) Polypeptide und nukleinsäuren, die diese codieren
DE602004019556D1 (de) Neues plexin-polypeptid, dieses codierende dna und verwendung davon
WO2002083847A3 (en) Cdna encoding the human alpha2 delta4 calcium channel subunit
ATE489463T1 (de) Polypeptid mit einer delta-5-fettsäure- desaturierungsaktivität, für das polypeptid codierendes polynukleotid und verwendung davon.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties